Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease
Article Date
October 1, 2023
This article is featured on another website.
Go to article
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…